Piotr Donizy

1.4k total citations
90 papers, 1.0k citations indexed

About

Piotr Donizy is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Piotr Donizy has authored 90 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 35 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Piotr Donizy's work include Ocular Oncology and Treatments (11 papers), Cancer Cells and Metastasis (11 papers) and Immunotherapy and Immune Responses (10 papers). Piotr Donizy is often cited by papers focused on Ocular Oncology and Treatments (11 papers), Cancer Cells and Metastasis (11 papers) and Immunotherapy and Immune Responses (10 papers). Piotr Donizy collaborates with scholars based in Poland, United States and Taiwan. Piotr Donizy's co-authors include Agnieszka Hałoń, Rafał Matkowski, Paweł Surowiak, Przemysław Biecek, Maciej Kaczorowski, Tserenchunt Gansukh, Hermann Lage, Mai P. Hoang, Bożena Romanowska‐Dixon and Anna Markiewicz and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Journal of the American Academy of Dermatology.

In The Last Decade

Piotr Donizy

84 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piotr Donizy Poland 18 460 427 187 157 100 90 1.0k
Sunandana Chandra United States 16 817 1.8× 424 1.0× 334 1.8× 122 0.8× 206 2.1× 49 1.2k
Hui Zhou China 21 371 0.8× 525 1.2× 188 1.0× 230 1.5× 178 1.8× 104 1.3k
Ning Liu China 20 242 0.5× 428 1.0× 159 0.9× 148 0.9× 156 1.6× 97 1.0k
Hidehisa Horiguchi Japan 18 138 0.3× 238 0.6× 197 1.1× 144 0.9× 152 1.5× 41 1.0k
Sabino Strippoli Italy 19 384 0.8× 371 0.9× 274 1.5× 116 0.7× 104 1.0× 51 842
Dedeepya Vaka United States 13 399 0.9× 665 1.6× 401 2.1× 205 1.3× 169 1.7× 18 1.4k
Ying Lin China 14 206 0.4× 1.2k 2.8× 391 2.1× 545 3.5× 103 1.0× 52 1.6k
Saveria Tropea Italy 13 413 0.9× 302 0.7× 121 0.6× 99 0.6× 166 1.7× 43 998

Countries citing papers authored by Piotr Donizy

Since Specialization
Citations

This map shows the geographic impact of Piotr Donizy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Donizy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Donizy more than expected).

Fields of papers citing papers by Piotr Donizy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Donizy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Donizy. The network helps show where Piotr Donizy may publish in the future.

Co-authorship network of co-authors of Piotr Donizy

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Donizy. A scholar is included among the top collaborators of Piotr Donizy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Donizy. Piotr Donizy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Górska, Agata, Paweł Karpiński, Anna Markiewicz, et al.. (2024). Co-Targeting of DTYMK and PARP1 as a Potential Therapeutic Approach in Uveal Melanoma. Cells. 13(16). 1348–1348. 1 indexed citations
3.
4.
Szumera‐Ciećkiewicz, Anna, Daniela Massi, Przemysław Biecek, et al.. (2023). SATB2, CKAE1/AE3, and synaptophysin as a sensitive immunohistochemical panel for the detection of lymph node metastases of Merkel cell carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 484(4). 629–636. 6 indexed citations
5.
Pergaris, Alexandros, Georgia Levidou, Nathalie Cassoux, et al.. (2022). EPHA2, EPHA4, and EPHA6 Expression in Uveal Melanomas: Searching for the Culprits of Neoplasia. Diagnostics. 12(5). 1025–1025. 3 indexed citations
6.
Donizy, Piotr, Hanna Augustyniak‐Bartosik, Mirosław Banasik, et al.. (2022). Biomarkers in Primary Focal Segmental Glomerulosclerosis in Optimal Diagnostic-Therapeutic Strategy. Journal of Clinical Medicine. 11(12). 3292–3292. 12 indexed citations
7.
Donizy, Piotr, Anna Markiewicz, Paweł Karpiński, et al.. (2022). Machine learning models demonstrate that clinicopathologic variables are comparable to gene expression prognostic signature in predicting survival in uveal melanoma. European Journal of Cancer. 174. 251–260. 10 indexed citations
8.
Levidou, Georgia, Nathalie Cassoux, Piotr Donizy, et al.. (2021). Histone Deacetylase (HDAC)-1, -2, -4, and -6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients’ Survival. Cancers. 13(19). 4763–4763. 14 indexed citations
9.
Simiczyjew, Aleksandra, Ewelina Dratkiewicz, Artur Beberok, et al.. (2021). PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma—A Clinical and an In Vitro Study. Cells. 10(2). 286–286. 16 indexed citations
10.
Banasik, Mirosław, Piotr Donizy, Katarzyna Kościelska−Kasprzak, et al.. (2021). Endothelin A Receptors Expressed in Glomeruli of Renal Transplant Patients May Be Associated with Antibody-Mediated Rejection. Journal of Clinical Medicine. 10(3). 422–422. 9 indexed citations
11.
Konieczny, Andrzej, Piotr Donizy, Tomasz Gołębiowski, et al.. (2021). Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome. Diagnostics. 11(10). 1764–1764. 9 indexed citations
12.
Donizy, Piotr, Joanna Wróblewska, Dora Dias‐Santagata, et al.. (2021). Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles. Cancers. 13(7). 1621–1621. 12 indexed citations
13.
Donizy, Piotr, Przemysław Biecek, Agnieszka Hałoń, Adam Maciejczyk, & Rafał Matkowski. (2017). Nucleoli cytomorphology in cutaneous melanoma cells – a new prognostic approach to an old concept. Diagnostic Pathology. 12(1). 88–88. 17 indexed citations
14.
Sebastian, Agata, et al.. (2017). The variety of clinical presentations in IgG4-related disease in Rheumatology. Rheumatology International. 38(2). 303–309. 6 indexed citations
16.
Donizy, Piotr, Agnieszka Hałoń, Tserenchunt Gansukh, et al.. (2014). Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph node-negative early breast cancer: 15-year follow-up. Oncology Reports. 31(4). 1777–1787. 23 indexed citations
17.
Donizy, Piotr, et al.. (2014). Cancer awareness and socioeconomic status are associated with mammography screening participation and early detection of breast cancer. Family Medicine & Primary Care Review. 329–332.
18.
Donizy, Piotr, et al.. (2014). Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.. PubMed. 34(6). 3113–8. 7 indexed citations
19.
Hałoń, Agnieszka, Piotr Donizy, Paweł Surowiak, & Rafał Matkowski. (2013). ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up. Cellular Oncology. 36(3). 181–190. 31 indexed citations
20.
Hałoń, Agnieszka & Piotr Donizy. (2012). [The role of the ERM protein family in maintaining cellular polarity, adhesion and regulation of cell motility].. PubMed. 66. 158–64. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026